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Background: Compared to first generation drug eluting stents (G1-DES), second generation DES (G2-DES) have decreased strut thickness and rigidity, 
and concerns have arisen that G2-DES may be inferior in situations needing robust radial strength such as calcified or ostial lesions. Therefore, we 
compared G2- vs. G1-DES in heavily calcified lesions requiring rotational atherectormy (RA) during percutaneous coronary intervention (RA+PCI).
Methods: We identified 1593 patients (mean age 70.1 ± 10.4 yrs, 481 females) from our single centre registry who underwent RA+PCI with either 
G1- (Cypher or Taxus; 1127 patients) or G2-DES (Xience V or Promus; 466 patients). Relevant data were extracted and imputed for analysis.
Results: Patient groups were well matched. Total implanted DES length was slightly longer for G1-DES (26.7 ± 9.2 vs. 25.2 ± 8.2 mm, p = 0.002, 
G1- vs. G2-DES all comparisons), but number of DES implanted and mean DES diameter were identical. Rates of in-hospital death, myocardial 
infarction (MI), target vessel revascularization (TVR) did not differ. Combining these outcomes, MACE rates at hospital discharge and at 30 days were 
not different between G1- and G2-DES (1.4 vs. 2.6%, p = 0.14; 5.2% vs. 8.0%, p = 0.16). Clinical outcomes did not differ between G1- and G2-DES 
at long term follow up (Figure).
Conclusions: Despite theoretical concerns, compared to G1-DES the use of G2-DES is associated with equivalent acute and long-term clinical 
outcomes in heavily calcified lesions requiring RA+PCI. 
